Ventilator-associated pneumonia in the era of COVID-19 pandemic: How common and what is the impact?

Paul-Henri Wicky; Michael S Niedermann; Jean-François Timsit

doi:10.1186/s13054-021-03571-z

Ventilator-associated pneumonia in the era of COVID-19 pandemic: How common and what is the impact?

Crit Care. 2021 Apr 21;25(1):153. doi: 10.1186/s13054-021-03571-z.

Authors

Paul-Henri Wicky¹, Michael S Niedermann^{2

3}, Jean-François Timsit^{4

5}

Affiliations

¹ Medical and Infectious Diseases ICU (MI2), AP-HP, Bichat Hospital, 75018, Paris, France.
² Department of Medicine, Weill Cornell Medicine, New York, USA.
³ Pulmonary and Critical Care Medicine, New York Presbyterian/Weill Cornell Medical Center, New York, USA.
⁴ Medical and Infectious Diseases ICU (MI2), AP-HP, Bichat Hospital, 75018, Paris, France. jean-francois.timsit@aphp.fr.
⁵ IAME, INSERM, University of Paris, 75018, Paris, France. jean-francois.timsit@aphp.fr.

Abstract

We reviewed similarities and differences of ventilator associated pneumonia in Sars-Cov2 infection and with other ARDS. The differences in epidemiology and outcome will be detailed. Possible explanations of differences in pathophysiology of VAP in Sarscov2 infections will be cited and discussed.

Keywords: ARDS; COVID-19; Prognostic; Superinfections; Ventilation-associated pneumonia.

Publication types

Editorial
Research Support, Non-U.S. Gov't
Review

MeSH terms

COVID-19*
Humans
Pneumonia, Ventilator-Associated / epidemiology*